Department of Endocrine Surgery, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, Wales, UK.
World J Surg. 2010 Jun;34(6):1151-6. doi: 10.1007/s00268-009-0297-7.
The eponym "Graves' disease" is usually applied to the condition of immunogenic hyperthyroidism, in no small part due to the promotion and influence of the French physician Armand Trousseau who wrote in 1862, "Du Goître Exophthalmique, ou Maladie de Graves." However, the distinguished Bath physician Caleb Hillier Parry, a friend of both Edward Jenner and John Hunter, first described the clinical picture of thyrotoxicosis associated with exophthalmos and cardiac dysfunction in a paper published posthumously in 1825, some 10 years before Robert Graves' initial report. Graves was unaware of Parry's earlier description and considered that the thyroid condition in the four female cases that he studied might be secondary to functional cardiac disorders and palpitations. The many outstanding contributions to medicine and science of Parry and Graves, two truly remarkable nineteenth century Celtic physicians, are compared and discussed. A case is made for considering the renaming of immunogenic hyperthyroidism as Parry's disease, a proposal made by Sir William Osler, who was the first to recognise Parry's claim for priority for the recognition of exophthalmic goitre.
“格雷夫斯病”这个名称通常用于描述免疫性甲状腺功能亢进症，这在很大程度上要归功于法国医生阿尔芒·特鲁索（Armand Trousseau）的推广和影响，他在 1862 年写道：“Du Goître Exophthalmique，ou Maladie de Graves。”然而，杰出的巴斯医生凯莱布·希利尔·帕里（Caleb Hillier Parry），既是爱德华·詹纳（Edward Jenner）又是约翰·亨特（John Hunter）的朋友，早在罗伯特·格雷夫斯（Robert Graves）最初报告的 10 年前，就在 1825 年发表的一篇遗著中首次描述了与眼球突出和心脏功能障碍相关的甲状腺毒症的临床特征。格雷夫斯并不知道帕里的早期描述，他认为他研究的 4 例女性甲状腺疾病可能是继发于功能性心脏疾病和心悸。本文比较和讨论了帕里和格雷夫斯这两位真正杰出的 19 世纪凯尔特医生对医学和科学的许多杰出贡献。有人提议将免疫性甲状腺功能亢进症重新命名为帕里病，这一提议是由威廉·奥斯勒爵士（Sir William Osler）提出的，他是第一个承认帕里对识别甲状腺眼病的优先权的人。
